The center will be fully operational in two years' time, but probably in the middle of the year we will have a temporary laboratory of 4,000 square feet.
I am very puzzled by the fact that young people are getting infected again. They don't take precautions despite an enormous amount of information. It's like riding a race car at 200 kilometers an hour. Some people like the risk.
I think we should put the same weight now on the co-factors as we have on HIV.
It's clear that prevention will never be sufficient. That's why we need a vaccine that will be safe.
It's very difficult in our society. You cannot impose certain behavioral changes. Education can do it at the right time, probably by high school. After that it is too late.
My proposal now is to test a vaccine first on people who have been infected, and if you show some efficacy at this level, you might be able to go further to study uninfected people in a population with a high rate of infection.
One could not have isolated this retrovirus without knowledge of other retroviruses, that's obvious. But I believe we have answered the criteria of isolation.
Our goal is not to completely eradicate the infection - that would be very difficult - but to produce a vaccine that will prevent not infection but disease. I think this is more possible.
Psychological factors are critical in supporting immune function. If you suppress this psychological support by telling someone he's condemned to die, your words alone will have condemned him.
Basic research is very useful, but it should be more geared toward application than it was before.
That is why it is so important not only to have excellent treatment but also to try to get back the immune defense, because there you have a natural defense that takes place everywhere.
I've participated in meetings where there were concerns by ethical experts. There is no clear solution.
The idea of the live-virus vaccine is to produce in a continuous way some viral antigens.
They don't actually see the real world, where 95% of the people with HIV are not treated and are dying. And even though we have some blue sky now in our country, the sky could become cloudy again very soon.
We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody.